153 related articles for article (PubMed ID: 37300531)
1. Microglial LRRK2-mediated NFATc1 attenuates α-synuclein immunotoxicity in association with CX3CR1-induced migration and the lysosome-initiated degradation.
Feng L; Lo H; Hong Z; Zheng J; Yan Y; Ye Z; Chen X; Pan X
Glia; 2023 Sep; 71(9):2266-2284. PubMed ID: 37300531
[TBL] [Abstract][Full Text] [Related]
2. LRRK2 mediates microglial neurotoxicity via NFATc2 in rodent models of synucleinopathies.
Kim C; Beilina A; Smith N; Li Y; Kim M; Kumaran R; Kaganovich A; Mamais A; Adame A; Iba M; Kwon S; Lee WJ; Shin SJ; Rissman RA; You S; Lee SJ; Singleton AB; Cookson MR; Masliah E
Sci Transl Med; 2020 Oct; 12(565):. PubMed ID: 33055242
[TBL] [Abstract][Full Text] [Related]
3. Parkinson's Disease-Associated LRRK2 Interferes with Astrocyte-Mediated Alpha-Synuclein Clearance.
Streubel-Gallasch L; Giusti V; Sandre M; Tessari I; Plotegher N; Giusto E; Masato A; Iovino L; Battisti I; Arrigoni G; Shimshek D; Greggio E; Tremblay ME; Bubacco L; Erlandsson A; Civiero L
Mol Neurobiol; 2021 Jul; 58(7):3119-3140. PubMed ID: 33629273
[TBL] [Abstract][Full Text] [Related]
4. LRRK2 modulates microglial activity through regulation of chemokine (C-X3-C) receptor 1 -mediated signalling pathways.
Ma B; Xu L; Pan X; Sun L; Ding J; Xie C; Koliatsos VE; Cai H
Hum Mol Genet; 2016 Aug; 25(16):3515-3523. PubMed ID: 27378696
[TBL] [Abstract][Full Text] [Related]
5. Fractalkine Signaling Regulates the Inflammatory Response in an α-Synuclein Model of Parkinson Disease.
Thome AD; Standaert DG; Harms AS
PLoS One; 2015; 10(10):e0140566. PubMed ID: 26469270
[TBL] [Abstract][Full Text] [Related]
6. Cx3cr1-deficiency exacerbates alpha-synuclein-A53T induced neuroinflammation and neurodegeneration in a mouse model of Parkinson's disease.
Castro-Sánchez S; García-Yagüe ÁJ; López-Royo T; Casarejos M; Lanciego JL; Lastres-Becker I
Glia; 2018 Aug; 66(8):1752-1762. PubMed ID: 29624735
[TBL] [Abstract][Full Text] [Related]
7. Familial knockin mutation of LRRK2 causes lysosomal dysfunction and accumulation of endogenous insoluble α-synuclein in neurons.
Schapansky J; Khasnavis S; DeAndrade MP; Nardozzi JD; Falkson SR; Boyd JD; Sanderson JB; Bartels T; Melrose HL; LaVoie MJ
Neurobiol Dis; 2018 Mar; 111():26-35. PubMed ID: 29246723
[TBL] [Abstract][Full Text] [Related]
8. Role of α-synuclein in microglia: autophagy and phagocytosis balance neuroinflammation in Parkinson's disease.
Lv QK; Tao KX; Wang XB; Yao XY; Pang MZ; Liu JY; Wang F; Liu CF
Inflamm Res; 2023 Mar; 72(3):443-462. PubMed ID: 36598534
[TBL] [Abstract][Full Text] [Related]
9. Transcriptome analysis of LRRK2 knock-out microglia cells reveals alterations of inflammatory- and oxidative stress-related pathways upon treatment with α-synuclein fibrils.
Russo I; Kaganovich A; Ding J; Landeck N; Mamais A; Varanita T; Biosa A; Tessari I; Bubacco L; Greggio E; Cookson MR
Neurobiol Dis; 2019 Sep; 129():67-78. PubMed ID: 31102768
[TBL] [Abstract][Full Text] [Related]
10. Leucine-rich repeat kinase 2 (LRRK2) regulates α-synuclein clearance in microglia.
Maekawa T; Sasaoka T; Azuma S; Ichikawa T; Melrose HL; Farrer MJ; Obata F
BMC Neurosci; 2016 Nov; 17(1):77. PubMed ID: 27903237
[TBL] [Abstract][Full Text] [Related]
11. Formation of templated inclusions in a forebrain α-synuclein mouse model is independent of LRRK2.
Dues DJ; Ma Y; Nguyen APT; Offerman AV; Beddows I; Moore DJ
Neurobiol Dis; 2023 Nov; 188():. PubMed ID: 38435455
[TBL] [Abstract][Full Text] [Related]
12. The complex relationships between microglia, alpha-synuclein, and LRRK2 in Parkinson's disease.
Schapansky J; Nardozzi JD; LaVoie MJ
Neuroscience; 2015 Aug; 302():74-88. PubMed ID: 25284317
[TBL] [Abstract][Full Text] [Related]
13. LRRK2 G2019S Mutation Inhibits Degradation of α-Synuclein in an In Vitro Model of Parkinson's Disease.
Hu D; Niu JY; Xiong J; Nie SK; Zeng F; Zhang ZH
Curr Med Sci; 2018 Dec; 38(6):1012-1017. PubMed ID: 30536063
[TBL] [Abstract][Full Text] [Related]
14. Age-dependent accumulation of oligomeric SNCA/α-synuclein from impaired degradation in mutant LRRK2 knockin mouse model of Parkinson disease: role for therapeutic activation of chaperone-mediated autophagy (CMA).
Ho PW; Leung CT; Liu H; Pang SY; Lam CS; Xian J; Li L; Kung MH; Ramsden DB; Ho SL
Autophagy; 2020 Feb; 16(2):347-370. PubMed ID: 30983487
[TBL] [Abstract][Full Text] [Related]
15. Brain and Cerebrospinal Fluid α-Synuclein Real-Time Quaking-Induced Conversion Identifies Lewy Body Pathology in LRRK2-PD.
Garrido A; Fairfoul G; Tolosa E; Marti MJ; Ezquerra M; Green AJE
Mov Disord; 2023 Feb; 38(2):333-338. PubMed ID: 36471633
[TBL] [Abstract][Full Text] [Related]
16. A breakdown in microglial metabolic reprogramming causes internalization dysfunction of α-synuclein in a mouse model of Parkinson's disease.
Lu J; Wang C; Cheng X; Wang R; Yan X; He P; Chen H; Yu Z
J Neuroinflammation; 2022 May; 19(1):113. PubMed ID: 35599331
[TBL] [Abstract][Full Text] [Related]
17. LRRK2 Inhibition Mitigates the Neuroinflammation Caused by TLR2-Specific α-Synuclein and Alleviates Neuroinflammation-Derived Dopaminergic Neuronal Loss.
Ho DH; Nam D; Seo M; Park SW; Seol W; Son I
Cells; 2022 Mar; 11(5):. PubMed ID: 35269482
[TBL] [Abstract][Full Text] [Related]
18. Dysregulated Wnt and NFAT signaling in a Parkinson's disease LRRK2 G2019S knock-in model.
Wetzel A; Lei SH; Liu T; Hughes MP; Peng Y; McKay T; Waddington SN; Grannò S; Rahim AA; Harvey K
Sci Rep; 2024 May; 14(1):12393. PubMed ID: 38811759
[TBL] [Abstract][Full Text] [Related]
19. Loss of cannabinoid receptor 2 promotes α-Synuclein-induced microglial synaptic pruning in nucleus accumbens by modulating the pCREB-c-Fos signaling pathway and complement system.
Feng L; Lo H; You H; Wu W; Cheng X; Xin J; Ye Z; Chen X; Pan X
Exp Neurol; 2023 Jan; 359():114230. PubMed ID: 36162511
[TBL] [Abstract][Full Text] [Related]
20. FcγRIIB mediates the inhibitory effect of aggregated α-synuclein on microglial phagocytosis.
Choi YR; Kang SJ; Kim JM; Lee SJ; Jou I; Joe EH; Park SM
Neurobiol Dis; 2015 Nov; 83():90-9. PubMed ID: 26342897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
